Published in Medicine and Law Weekly, June 30th, 2006
Study 1: Cardiac resynchronization therapy (CRT) with implantation of a left ventricular lead is feasible and safe in patients with congestive heart failure, although there are some procedural complications.
According to recent research from the People's Republic of China, "Previous clinical studies have suggested that patients with congestive heart failure and intraventricular conduction delay could benefit from CRT. Implantation of left ventricular lead is a complex procedure with some potential for complications."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly